RESEARCH-USE BIOSIMILAR ANTIBODY
Veltuzumab
Monoclonal antibody · IgG1
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL).
TARGETMS4A1
YMonoclonal antibody
CATALOGSC-BS-044
CATALOG NUMBERSC-BS-044
MOLECULAR WEIGHTApprox. 145.34 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Veltuzumab (IMMU-106) is a humanized anti-CD20 monoclonal antibody. Veltuzumab has low EC50 value of 0.08-0.09 μg/mL in the Daudi cell line. Veltuzumab can be used for the research of cancer including non-Hodgkin lymphoma (NHL).
Veltuzumab is a recombinant research-use antibody directed against MS4A1.